Literature DB >> 1963921

Synthesis and localization of Japanese encephalitis virus RNAs in the infected cells.

T Takegami1, S Hotta.   

Abstract

Synthesis and localization of virus-specific RNA in cells infected with Japanese encephalitis virus (JEV) were examined. To prepare specific RNA probes, we constructed four kinds of plasmids which contained DNA fragments corresponding to JEV genomic RNA. Minus probes, JT18V and JT19III, transcribed by T7 RNA polymerase were able to recognize a negative strand of JEV-specific RNA synthesized in cells as early as 6 hr postinfection (p.i.). In the experiments using a plus-strand probe JT19V to hybridize the 3' end of JEV-RNA, not only full-length 42S(+) RNA but also 10S(+) RNA were detected in the infected cells at 24 hr p.i. The positive-strand 42S RNA was found in much greater abundance in the membrane fraction than in the supernatant fraction of the infected cells. In contrast, larger amounts of the negative-strand RNAs existed in the supernatant fraction. It is suggested from the data that the JEV-specific negative- and positive-strand RNAs accumulate at different sites in the infected cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963921     DOI: 10.1111/j.1348-0421.1990.tb01063.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  10 in total

1.  Nuclear localization of flavivirus RNA synthesis in infected cells.

Authors:  Pradeep Devappa Uchil; Anil V A Kumar; Vijaya Satchidanandam
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  Accumulation of a 3'-terminal genome fragment in Japanese encephalitis virus-infected mammalian and mosquito cells.

Authors:  Kuo-Chih Lin; Huei-Lan Chang; Ruey-Yi Chang
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

3.  A viral noncoding RNA generated by cis-element-mediated protection against 5'->3' RNA decay represses both cap-independent and cap-dependent translation.

Authors:  Hiro-Oki Iwakawa; Hiroyuki Mizumoto; Hideaki Nagano; Yuka Imoto; Kazuma Takigawa; Siriruk Sarawaneeyaruk; Masanori Kaido; Kazuyuki Mise; Tetsuro Okuno
Journal:  J Virol       Date:  2008-08-13       Impact factor: 5.103

Review 4.  Genome cyclization as strategy for flavivirus RNA replication.

Authors:  Sergio M Villordo; Andrea V Gamarnik
Journal:  Virus Res       Date:  2008-09-09       Impact factor: 3.303

5.  Japanese encephalitis virus nonstructural protein NS3 has RNA binding and ATPase activities.

Authors:  T Takegami; D Sakamuro; T Furukawa
Journal:  Virus Genes       Date:  1995-01       Impact factor: 2.332

6.  Small noncoding RNA modulates Japanese encephalitis virus replication and translation in trans.

Authors:  Yi-Hsin Fan; Muthukumar Nadar; Chiu-Chin Chen; Chia-Chen Weng; Yun-Tong Lin; Ruey-Yi Chang
Journal:  Virol J       Date:  2011-11-01       Impact factor: 4.099

7.  Actively replicating West Nile virus is resistant to cytoplasmic delivery of siRNA.

Authors:  Brian J Geiss; Theodore C Pierson; Michael S Diamond
Journal:  Virol J       Date:  2005-06-28       Impact factor: 4.099

8.  Sphingomyelin generated by sphingomyelin synthase 1 is involved in attachment and infection with Japanese encephalitis virus.

Authors:  Makoto Taniguchi; Takafumi Tasaki; Hideaki Ninomiya; Yoshibumi Ueda; Koh-Ichi Kuremoto; Susumu Mitsutake; Yasuyuki Igarashi; Toshiro Okazaki; Tsutomu Takegami
Journal:  Sci Rep       Date:  2016-11-28       Impact factor: 4.379

9.  Sequence duplication in 3' UTR modulates virus replication and virulence of Japanese encephalitis virus.

Authors:  Qiu-Yan Zhang; Si-Qing Liu; Xiao-Dan Li; Jia-Qi Li; Ya-Nan Zhang; Cheng-Lin Deng; Hong-Lei Zhang; Xu-Fang Li; Chun-Xiao Fang; Feng-Xia Yang; Bo Zhang; Yi Xu; Han-Qing Ye
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 7.163

10.  Identification and characterization of RNA-dependent RNA polymerase activity in recombinant Japanese encephalitis virus NS5 protein.

Authors:  F Yu; F Hasebe; S Inoue; E G M Mathenge; K Morita
Journal:  Arch Virol       Date:  2007-06-18       Impact factor: 2.574

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.